Efficacy of Multimodal Analgesia Following Hip Arthroscopy
Summary
The purpose of the full study is to determine whether multimodal analgesia for hip arthroscopy will reduce post-operative pain scores, narcotic consumption and hospital length-of-stay. To do this, the investigators will compare the standard of care (SOC), with routine pain management with a post-operative opioid prescription, to three different groups with multi-modal analgesia (SOC+peri-operative celecoxib, SOC+peri-operative gabapentin, and SOC+post-operative zopiclone). The investigators hypothesize that administration of multi-modal analgesia in all three treatment groups will result in improved post-operative pain control, reduced post-operative narcotic consumption and an overall reduction in post-operative length-of-stay compared to the group receiving treatment as per the standard of care. However, prior to undertaking a large multi-centre study, the investigators need to determine whether the study is feasible from data obtained with this pilot study.
Timeline
- Start
- 2018-04-06
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 400 mg | Oral |
| Subject | Gabapentin | Small molecule | 600 mg | Oral |
| Subject | Zopiclone | Small molecule | 7.5 mg | Oral |
| Background | Naproxen | Small molecule | 500 mg | — |
| Background | Oxycodone | Other / unclassified | 5 mg | — |
| Background | Oxycodone | Other / unclassified | 325 mg | — |